Ribavirin: pharmacology, multiple modes of action and possible future perspectives | Future Virology
Sofosbuvir - Wikipedia
PathWhiz
Advances in Treatment of Hepatitis C | IntechOpen
Plant Uptake and Metabolism of 2,4-Dibromophenol in Carrot: In Vitro Enzymatic Direct Conjugation | Journal of Agricultural and Food Chemistry
Discovery of New Inhibitors of Hepatitis C Virus NS3/4A Protease and Its D168A Mutant | ACS Omega
Amino Acid and Peptide‐Based Antiviral Agents - Skwarecki - 2021 - ChemMedChem - Wiley Online Library
Therapeutics for COVID-19: from computation to practices—where we are, where we are heading to | SpringerLink
New perspectives for preventing hepatitis C virus liver graft infection - The Lancet Infectious Diseases
Sofosbuvir/velpatasvir: A promising combination
Velpatasvir | C49H54N8O8 - PubChem
Epclusa, INN-sofosbuvir/velpatasvir
Frontiers | Drug-drug interactions between antithrombotics and direct-acting antivirals in hepatitis C virus (HCV) patients: A brief, updated report
Sofosbuvir terminated RNA is more resistant to SARS-CoV-2 proofreader than RNA terminated by Remdesivir | Scientific Reports
Recent advances in managing chronic HCV... | F1000Research
Sofosbuvir, a Significant Paradigm Change in HCV Treatment
Sofosbuvir/Velpatasvir (Epclusa®) Drug Interactions A Quick Guide for Clinicians – February 2019
Use of Ribavirin for Hepatitis C Treatment in the Modern Direct-acting Antiviral Era
Sofosbuvir/Velpatasvir/Voxilaprevir: A Highly Effective Option for Retreatment of Hepatitis C in Difficult-to-treat Patients - Poonam Mathur, Shyamasundaran Kottilil, Eleanor Wilson, 2019
Frontiers | Update on Antiviral Strategies Against COVID-19: Unmet Needs and Prospects
Direct-acting antiviral agents for hepatitis C: structural and mechanistic insights | Nature Reviews Gastroenterology & Hepatology
Sofosbuvir - Wikipedia
Antivirals for Hepatitis C | Concise Medical Knowledge
Current targets and drug candidates for prevention and treatment of SARS-CoV-2 (COVID-19) infection
